Recent Articles

• Tech tricks that could prevent future COVID-19 outbreaks in your healthcare…

  Lisa Mulcahy Pharmaceutical

  Even as the COVID-19 pandemic finally seems to be showing signs of slowing down in the U.S., you know as a hospital administrator or physician that you still can't take your eye off the ball in terms of prevention strategy. One of your top priorities will be stopping any further coronavirus spread in your facility until herd immunity and/or highly controlled case counts have been reached in your region, so you need up-to-date solutions your staff can swiftly and easily implement. The following cutting-edge techniques can mean simplified and highly effective infection control for your organization.

• Infographic: Pandemic digital health trends you should know

  Brian Wallace Pharmaceutical

  The COVID-19 pandemic brought a rapid acceleration in digital health services and telemedicine. Much of the digital transformation in healthcare has been driven by patient expectations and has little to do with doctors' age or level of experience. Today, physicians are more likely to recommend health-related smartphone apps, fitness wearables and other technology to their patients. Many use social media to engage with and educate patients. In fact, 87% of doctors who are high digital adopters share educational videos with patients regularly.

• Infographic: Digital messaging and the future of healthcare

  Brian Wallace Pharmaceutical

  As people grow accustomed to messaging retailers, restaurants, and customer service agents, they’re beginning to expect the same from their doctors. Seventy percent of people want to communicate with their doctor through text messaging. The benefits of messaging for healthcare providers go far beyond convenience and patient satisfaction. Using automated reminders encourage patients to keep scheduled appointments, schedule follow-up care, and keep their prescriptions filled. These measures reduce costs for providers and improve patients’ health at the same time.

• Telemedicine post-COVID: How to implement key lessons from the pandemic…

  Lisa Mulcahy Pharmaceutical

  As you no doubt have learned as a healthcare administrator or professional throughout the COVID-19 crisis, telemedicine is hugely beneficial when it comes to quick triage and treatment of patients at a distance. But that's not the only way you can incorporate this universal technology to help your hospital, clinics or office locations run better. New research is outlining fresh ways you can use telemedicine now and in the future to optimize how well your organization runs. Here are three areas you can focus on.

• Podcast: How to maximize word-of-mouth referrals for a cash-based practice

  Jarod Carter Pharmaceutical

  Word-of-mouth referrals can be one of the easiest, lowest-cost ways to attract new patients to a cash-based practice. While this form of marketing can often be considered quite passive, there are a number of fairly easy things you can do that will improve your results. By employing these tactics, you’ll enhance your online credibility, powerfully connect with your target customer, and dramatically increase your word-of-mouth referrals. In this podcast, Jarod Carter discusses specific strategies that will maximize your word-of-mouth referrals.

• Meeting your employees’ mental health concerns and needs

  Terri Williams Pharmaceutical

  The year 2020 brought anxiety and depression to many workers. The CDC reported that three times as many adults said they felt anxiety and four times as many adults said they felt depressed in the summer of 2020 compared to the summer of 2019. According to a survey commissioned by Spring Health and conducted online by The Harris Poll, 49% of American workers sought mental healthcare in 2020; 38% of those who sought care say they were driven by a desire to manage emotions related to the coronavirus pandemic; and 43% said the mental health benefits in their employer-sponsored health plan did not meet their mental healthcare needs.

• The delicate balance of supply and demand for COVID-19 vaccines

  Bambi Majumdar Pharmaceutical

  President Joe Biden rolled out strategies to combat and control the coronavirus pandemic on his first day in the Oval Office. A national vaccination campaign aims to administer 100 million shots to cover 50 million Americans in his first 100 days in office. Led by Dr. Anthony Fauci and other medical experts, pandemic control actions will ramp up, such as travel restrictions, mandatory mask rules, increased testing, and more personal protective equipment. Along with orders to boost supplies for vaccination, the team will also focus on developing therapeutics to treat COVID-19.

• 5 reasons to build a healthcare brand for millennials

  Alexa Lemzy Pharmaceutical

  The millennial generation consists of people born between 1981 and 1996, making members of this group between the ages of 25 and 40 in 2021. As the demographic approaches middle age, their need for healthcare is increasing. As the largest generational group, this creates a huge market for healthcare brands ready to cater to their preferences. As a demographic, millennials differ from previous generations significantly in the way they choose services and respond to marketing. As a result, healthcare brands need to be built to meet these new demands.

• Infographic: What new tech means for nursing homes of the future

  Brian Wallace Pharmaceutical

  The COVID-19 pandemic has highlighted the need for quality nursing home care. While 25% of COVID-19 deaths come from nursing homes, the quality of the nursing home affects results: 4- to 5-star nursing homes had 94% lower risk than their 1-star peers. When the pandemic is over, those disparities will remain. As the population of America ages, nursing homes will house more people than ever in the coming years.

• Pandemic vaccines, patents and Uncle Sam

  Seth Sandronsky Pharmaceutical

  As the coronavirus pandemic tears through rural and urban America, healthcare workers and others at risk of catching the disease are receiving life-saving vaccines now. Meanwhile, in a new development, opposing views of vaccine policy are front and center in the U.S.' paper of record. First, we turn to the pharmaceutical industry, a powerhouse interest. Thomas Cueni is the director-general of the International Federation of Pharmaceutical Manufacturers and Associations.

• view all articles